Provided by Tiger Trade Technology Pte. Ltd.

Ampio Pharmaceuticals, Inc.

0.0100
0.0000
Volume:4.00
Turnover:0.04
Market Cap:11.35K
PE:0.00
High:0.0100
Open:0.0100
Low:0.0100
Close:0.0100
52wk High:0.2602
52wk Low:0.0001
Shares:1.14M
Float Shares:1.12M
Volume Ratio:0.02
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.6600
EPS(LYR):-10.6553
ROE:-113.96%
ROA:-61.57%
PB:0.00
PE(LYR):0.00

Loading ...

Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Voluntary Delisting

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 28, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Jan 26, 2024

Major Issues Report

Form 8-K - Current report
Jan 11, 2024

Major Issues Report

Form 8-K - Current report
Dec 22, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 07, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 28, 2023

Major Issues Report

Form 8-K - Current report
Oct 07, 2023

Major Issues Report

Form 8-K - Current report
Oct 05, 2023

Major Issues Report

Form 8-K - Current report
Sep 26, 2023

Correspondence

Form CORRESP - Correspondence
Sep 22, 2023

Major Issues Report

Form 8-K - Current report
Sep 01, 2023

Major Issues Report

Form 8-K - Current report